Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.

Authors
Publication date
1 January 2012
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Florence Research

    redirect
    oaioai:flore.unifi.it:2158/649662
    Last time updated on 17/04/2020